Furthermore, Hertzberg et al. [21] demonstrated that patients with Down syndrome–associated ALL harbored JAK2 mutations in association with altered CRLF2 overexpression, which in some patients was caused by an activating somatic mutation, F232C, in the CRLF2 gene. This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.